Laura T. Housman, MPH, MBA, DrPH(c)

Laura T. Housman, MPH, MBA, DrPH(c) has extensive experience in healthcare commercialization consulting, corporate and business development, digital engagement, pharmaceutical and biotech drug development access initiatives, and public policy and advocacy. Laura T. began their career in 2002 as the Director of Marketing and Market Access at Genzyme Genetics. In 2008, they moved to Charles River Laboratories as the Executive Director of Global Marketing. From 2009 to 2016, they were the Vice President of Global Market Access, Pricing, and HE&OR at Novartis. In 2016, they founded Access Solutions Consulting (ASC), where they delivered healthcare commercialization consulting in support of patients, providers, payors, and pharmaceutical organizations. In 2018, they became an Adjunct Faculty at the Massachusetts College of Pharmacy and Health Sciences, and in 2019, they were the Vice President/Head Access Outcomes and Population Health at Exact Sciences. In 2020, they became an Independent Board Director at SkinIO, and in 2022, they will be the Chief Commercial and Operations Officer at Olaris, Inc.

Laura T. Housman is currently a Doctor of Public Health (DrPh) candidate at Boston University, where they also hold an MBA from the Questrom School of Business. Laura T. also has an MPH from the Boston University School of Public Health and a BA in Economics with a minor in Business Administration from Boston University.